Therapy News and Research

RSS

CBT improves blood sugar control and brings faster relief of depression in patients with type 2 diabetes

Although maintaining good blood sugar control is crucial for avoiding complications of diabetes, it has been estimated that only about half of patients are successful in meeting target blood glucose levels.

25 Feb 2014

Study: Routine testing with FISH and IHC may enhance detection of ALK-positive NSCLC

The findings of a recent study indicate that routine testing with both fluorescent in situ hybridization (FISH) and immunohistochemistry (IHC) may enhance the detection of ALK-positive non-small cell lung cancer (NSCLC).

25 Feb 2014

Researchers develop novel technique for detecting ALK rearrangements in non-small cell lung cancers

Researchers have developed a novel technique for detecting ALK rearrangements in non-small cell lung cancers (NSCLCs) that is more sensitive and easier to perform than currently available techniques.

25 Feb 2014

Pregnant women with bipolar disorder more frequently have mental health

Pregnant and postpartum women with bipolar disorder more frequently have significant mental health and early mothering challenges than other perinatal women undergoing psychiatric treatment, according to a study in the Journal of Affective Disorders.

25 Feb 2014

FDA approves Iroko Pharmaceuticals’ TIVORBEX capsules

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that the U.S. Food and Drug Administration (FDA) has approved TIVORBEX™ (indomethacin) capsules, a nonsteroidal anti-inflammatory drug (NSAID), at 20 mg and 40 mg doses for the treatment of mild to moderate acute pain in adults.

25 Feb 2014

Passive stimulation improves sense of touch and motor skills in stroke patients

A team headed by PD Dr Hubert Dinse and Prof Dr Martin Tegenthoff has successfully treated a number of patients suffering from stroke-related impairments. Their report has been published in RUBIN, the Ruhr-Universit-t's science magazine.

25 Feb 2014

Enzalutamide shows added benefit in prostate cancer patients without visceral metastases

Enzalutamide (trade name: Xtandi) has been approved since June 2013 for men with metastatic prostate cancer in whom the commonly used hormone blockade is no longer effective and who have already been treated with the cytostatic drug docetaxel.

25 Feb 2014

European Commission invests nearly $475 million in gene transfer and gene therapy projects

Over the past three funding stages, the European Commission has invested nearly $475 million in 100 projects in the gene transfer and gene therapy field.

25 Feb 2014

Neurosurgeons use MRI-guided laser technology to treat deep brain tumor

Using a novel magnetic resonance imaging (MRI)-guided laser technology, neurosurgeons at UC San Diego Health System have successfully treated a malignant tumor deep inside a patient's brain. This is the first time that this FDA-approved laser-based treatment has been performed in California.

25 Feb 2014

Onset Dermatologics launches 75mg strength of MINOCIN pellet-filled capsules to treat bacterial infections

Onset Dermatologics, a leader in developing and commercializing prescription products for improving skin health, today announced the launch of a 75mg strength of MINOCIN (minocycline hydrochloride) Pellet-Filled Capsules.

25 Feb 2014

FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the current label of XELJANZ® (tofacitinib citrate) 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan (A3921044) and ORAL Start.

25 Feb 2014

Infliximab drug shows promising results in treating children with Kawasaki Disease

Kawasaki Disease (KD) is a severe childhood disease that many parents, even some doctors, mistake for an inconsequential viral infection. If not diagnosed or treated in time, it can lead to irreversible heart damage.

25 Feb 2014

UNM Cancer Center now adds stereotactic radiosurgery procedure to its list of treatment options

The UNM Cancer Center can now add stereotactic radiosurgery to its growing list of treatment options. This non-invasive outpatient procedure kills tumor cells in the brain in a single treatment.

24 Feb 2014

IRSF announces new research grants for translational research program and clinical trials

The International Rett Syndrome Foundation (IRSF) announces today ten (10) new research grants at leading global research institutions; a new Translational Research Program; and additional funding for current human clinical trials.

24 Feb 2014

Study suggests simple way for physicians to communicate treatment goals in type 2 diabetes patients

An editorial in a February issue of American Family Physician proposes a simple way for physicians to communicate with patients about the best treatments for diabetes. The "lending a hand" illustration reprioritizes treatment goals, based on research on mortality reduction, to convey that glycemic control is no longer the primary intervention.

24 Feb 2014

Tel Aviv University scientists target drug-resistant ovarian tumors with nanotechnology

Ovarian cancer accounts for more deaths of American women than any other cancer of the female reproductive system. According to the American Cancer Society, one in 72 American women will be diagnosed with ovarian cancer, and one in 100 will ultimately die of the condition.

24 Feb 2014

NCI recommends renewal for Wistar's Support Grant with award of $14.9M

After an extensive review by a panel of top cancer experts, the National Cancer Institute (NCI) rated The Wistar Institute Cancer Center as "exceptional" and recommended renewal for Wistar's Support Grant with an award of $14.9 million over the next five years.

24 Feb 2014

Neuroscientists develop stimulation glove for patients suffering from stroke-related impairments

Improving the sense of touch and motor skills without active training - what sounds impossible, does actually work. Neuroscientists at the Ruhr-Universität Bochum have developed a glove that uses weak electrical pulses to stimulate the nerve fibres that connect the hands with the brain.

24 Feb 2014

Researchers produce novel microparticles

A team of researchers of Karlsruhe Institute of Technology (KIT) and the University of Michigan/USA has produced novel microparticles, whose surface consists of three chemically different segments.

24 Feb 2014

Ellex gets CE Mark approval for 2RT laser treatment of early stage AMD

Ellex Medical Lasers Limited, a pioneer in medical technologies for the diagnosis and treatment of eye disease, today announced that it has secured a CE Mark (Conformité Européenne) for its proprietary Retinal Rejuvenation Therapy (2RT) laser treatment of early Age-Related Macular Degeneration (AMD).

24 Feb 2014

Therapy News and Research

CBT improves blood sugar control and brings faster relief of depression in patients with type 2 diabetes

Study: Routine testing with FISH and IHC may enhance detection of ALK-positive NSCLC

Researchers develop novel technique for detecting ALK rearrangements in non-small cell lung cancers

Pregnant women with bipolar disorder more frequently have mental health

FDA approves Iroko Pharmaceuticals’ TIVORBEX capsules

Passive stimulation improves sense of touch and motor skills in stroke patients

Enzalutamide shows added benefit in prostate cancer patients without visceral metastases

European Commission invests nearly $475 million in gene transfer and gene therapy projects

Neurosurgeons use MRI-guided laser technology to treat deep brain tumor

Onset Dermatologics launches 75mg strength of MINOCIN pellet-filled capsules to treat bacterial infections

FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

Infliximab drug shows promising results in treating children with Kawasaki Disease

UNM Cancer Center now adds stereotactic radiosurgery procedure to its list of treatment options

IRSF announces new research grants for translational research program and clinical trials

Study suggests simple way for physicians to communicate treatment goals in type 2 diabetes patients

Tel Aviv University scientists target drug-resistant ovarian tumors with nanotechnology

NCI recommends renewal for Wistar's Support Grant with award of $14.9M

Neuroscientists develop stimulation glove for patients suffering from stroke-related impairments

Researchers produce novel microparticles

Ellex gets CE Mark approval for 2RT laser treatment of early stage AMD

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News